Ewing Sarcoma Breakpoint Region 1 (EWSR1) (C-Term) Peptide
EWSR1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5511158
Quick Overview for Ewing Sarcoma Breakpoint Region 1 (EWSR1) (C-Term) Peptide (ABIN5511158)
Target
EWSR1
(Ewing Sarcoma Breakpoint Region 1 (EWSR1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- SQQNTYGQPS SYGQQSSYGQ QSSYGQQPPT SYPPQTGSYS QAPSQYSQQS
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-EWSR1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))
-
Background
-
EWSR1 is a putative RNA binding protein. Mutations in this gene, specifically a t(11,22)(q24,q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors.
Protein Size: 354 -
Gene ID
- 2130
Target
-
You are here:
